Cytovale Funding & Investors
Cytovale Inc. operates as a commercial physical and biological research and development firm. The Company develops novel microfluidic platform which allows users to probe individual cells to quantify the mechanical signatures of disease. Cytovale serves customers in the State of California.
cytovale.comTotal Amount Raised: $128,589,592
Cytovale Funding Rounds
Series C
$84,000,000
Series C Investors
Norwest Venture PartnersSands Capital VenturesGlobal Health InvestmentAlumni Ventures GroupDebt Financing
$16,435,000
Debt Financing Investors
Blackhorn VenturesPathway BioventuresBreakout VenturesDolby Family VenturesSeries B
$15,000,000
Series B Investors
Breakout VenturesBlackhorn VenturesWestern Technology InvestmentGRIDS CapitalSeries C
$84,000,000
Series C Investors
Norwest Venture PartnersSands Capital VenturesGlobal Health InvestmentAlumni Ventures GroupDebt Financing
$16,435,000
Debt Financing Investors
Blackhorn VenturesPathway BioventuresBreakout VenturesDolby Family VenturesSeries B
$7,249,989
Series B Investors
Blackhorn VenturesBreakout VenturesIT-FarmGrant
$1,419,607
Grant Investors
National Science Foundation (NSF)Series A
$4,300,000
Series A Investors
Dolby Family VenturesGrant
$184,998
Grant Investors
National Science Foundation (NSF)
Funding info provided by Diffbot.